Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Quest Diagnostics (NY:DGX)

178.24 +0.12 (+0.07%)
Official Closing Price Updated: 7:00 PM EDT, May 20, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Quest Diagnostics

< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Biden Administration Releases Revised Guidance For Medicare Drug Price Negotiation Amid Industry Lawsuits
The Centers for Medicare and Medicaid Services released revised guidance on using its authority with pharmaceutical manufacturers 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 29, 2023
Via Benzinga
Analyst Ratings for Quest Diagnostics
Via Benzinga
The Latest Analyst Ratings for Quest Diagnostics
Via Benzinga
Will Chart Analysts Notice Bad Omen on Quest Diagnostics's Chart
Via Benzinga
Quest Diagnostics Q1 Earnings Surpass Expectations; COVID-19 Testing Revenues Slump 80%
Via Benzinga
Analyst Expectations for Quest Diagnostics's Future
Via Benzinga
FDA Readies Proposal for Increased Oversight on Lab-developed Tests
The FDA is preparing to increase regulation of a widely used class of tests conducted by laboratories to detect cancer, measure cholesterol, and identify other health issues. The FDA is developing a... 
Via Benzinga
Want Growing Passive Income? Consider Buying This Stock
This maker of diagnostics tests has delivered 13 years of dividend growth to shareholders. 
Via The Motley Fool
Post-Accident Workforce Drug Positivity For Marijuana Reached 25-Year High In 2022, Quest Diagnostics Drug Testing Index Analysis Finds
The percentage of employees in the general U.S. workforce testing positive for marijuana following an on-the-job accident increased to its highest level in 25 years in 2022, according to a new analysis... 
Via Benzinga
Top 5 Health Care Stocks That Could Lead To Your Biggest Gains In May
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 2, 2023
Via Benzinga
Analyst Expectations for Quest Diagnostics's Future
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 3, 2023
Via Benzinga
Is This Healthcare Stock a Buy for Dividend Growth Investors?
This maker of diagnostics tests just announced that it will be sending more cash to its shareholders. 
Via The Motley Fool
2 Dividend Stocks That Recently Boosted Their Payouts by More Than 7%
These companies may not be finished raising their dividend payments as they both have low payout ratios. 
Via The Motley Fool
5 Analysts Have This to Say About Quest Diagnostics
Via Benzinga
Analyst Ratings for Quest Diagnostics
Via Benzinga
Where Quest Diagnostics Stands With Analysts
Via Benzinga
Golden Cross Appears Before Quest Diagnostics Investors
Via Benzinga
Where Quest Diagnostics Stands With Analysts
Via Benzinga
Why Quest Diagnostics Stock Jumped Today
Growth in the lab testing titan's core business is accelerating. 
Via The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For January 23, 2023
Via Benzinga
Down 40% in 2022, Can Exact Sciences Recover in 2023?
Investors are attracted to its leading position in the market for early cancer detection, but the persistent losses its been reporting are enough to make anyone nervous. 
Via The Motley Fool
Quest Diagnostics Q3 Earnings Surpass Expectations, Raises Annual Guidance
Via Benzinga
These 2 Defensive Plays Are Highlights Of CNBC's 'Final Trades'
On CNBC’s "Halftime Report: Final Trades," Shannon Saccocia of Boston Private said Quest Diagnostics Inc (NYSE: DGX) is expected to grow 4% to 5% 
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 17, 2022
Upgrades 
Via Benzinga
Quest Diagnostics To Plunge 16%? Here Are 5 Other Price Target Changes For Thursday
Via Benzinga
Quest Diagnostics: Q3 Earnings Insights
Quest Diagnostics (NYSE:DGX) reported its Q3 earnings results on Thursday, October 20, 2022 at 06:45 AM. Here's what investors need to know about the announcement. 
Via Benzinga
< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.